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Formation ofnitrite from ingested nitrate can result in sevral adverse health effects and implies a
genotoxic risk as a consequence ofendogenous formation ofcarcinogenic Nni compounds.
We studiedthe formation ofvolatileN-nitrosamines after intakeofnitrate atthe acceptabledaily
intake (ADI) level in combination with a fish meal rich in amines as nitrosatable precursors.
Twenty-five volunteers consumed this meal during 7 consective days; a diet low in nitrate was
consumed during l week before and 1 week after the test week Nitrate intake at the ADI level
resulted in a significant rise in mean slivary nitrate and nitrite concentrations. Mean urinary
nitrate excretion increased from 76 mg/24 hr in the first controlweek to 194 and 165 mg/24 hr
in the test week followed by adecline to 77mg/24 hrinthesecondcontrolweek The urine sm-
ples were analyzed for volatile N-nitroines, and both N-nitosdimetoyamine (NDMA) and
N-nirsopiperidine (NPIP) weredetectedinthesamples. Mean urinaryNDMA exceonsignifi-
candyincreasedfom 287 ng/24 hrin the controlweek to 871 and640 ng/24 hrin the tsweek
and decined to 383 ng124 hr in the second control week Excretion ofNPIP was not diret
related to the nitrate intake and composition of the diet Nitrate excretion and NDMA excretion
were significantly correlated, as well as salivary nitrate and nitrte concentation and NDMA
excretion. We Conclue that nitrate intake at theADI levd in combination with a fish meal con-
taining nitrosatable precursors increases NDMA excretion in urine and thus demonstrates
increased formation of ac NinogencNWnitrosamines. ICry wor amines, nitrate, N-nitrosamines,
N-nitrosodimethylamine. Environ Health Pmpect 106:459-463 (1998). [Online 1 July 1998]
btp:/ehpnetl.niehs.nibgov/doc/1998106p459-463vmwerlabstrac.btml
Humans are exposed to nitrate mainly as a
consequence offood intake and, to a lesser
extent, of drinking water consumption.
Vegetables are the principal source of
nitrate exposure, providing at least 85% of
the average daily nitrate intake when the
drinking water nitrate concentration is low
(e.g., 1-5 mg/l). The contribution ofdrink-
ing water intake to the nitrate load is
strongly dependent on the type of water
supply. The World Health Organization
(WHO) guidelines indicate a maximally
admissible nitrate concentration in drinking
water of 44.3 mg/l (1). Nitrate levels in
most European public drinking water sup-
plies seldom exceed 45 mg/lI. Private wells,
however, may contain as much as 300 mg/l
(2). WEIO states that nitrae levels in sur-
face waters and groundwaters have marked-
ly increased in the last decades due to
increased use of fertilizers, changes in land
use, and disposal of waste from intensive
animal farming, leading to an increased risk
ofhuman exposure (1).
Nitrate per se is relatively nontoxic, but
approximately 5% of all ingested nitrate is
converted to the more toxic nitrite (3-5).
Upon absorption in the bloodstream, nitrite
reacts with hemoglobin to form methemo-
globin, which is unable to transport oxygen
(6). Methemoglobinemia is considered to be
the major human health risk associated with
nitrate exposure. Infants are especially
sensitive to the formation of methemoglo-
bin. Based on the no-adverse-effect level
observed in animal studies, WHO has set
the acceptable daily intake (ADI) for nitrate
and nitrite, respectively, at 3.67 mg/kg
body weight and 0.13 mg/kg body weight
(expressed as nitrate and nitrite ion) (2).
Other adverse health effects of nitrate
exposure have been reported. Exposure to
high nitrate levels implies a genotoxic risk
for humans due to endogenous formation of
carcinogenic N-nitroso compounds. Nitrite
derived from nitrate may react in vivo with
amines and amides to form N-nitroso com-
pounds. About 300 N-nitroso compounds
(NOCs) have been tested for carcinogenicity
in experimental animals; 85% of the 209
nitrosamines and 92% of the 86 nitros-
amides have been shown to be carcinogenic
in a variety ofspecies (8). Human exposure
to endogenously formed NOCs has been
associated with an increased risk ofcancer of
thestomach, esophagus, and bladder (9-14].
Convincing epidemiological evidence for
human cancer risk, however, is still lacking.
Ward et al. (13) observed that long-term
exposure to elevated nitrate levels in drink-
ing water may contribute to the risk of non-
Hodgkin's lymphoma. Lin and Ho (14)
reported hepatocarcinogenic effects in rats of
endogenously formed NOCs after dietary
intake of amines in combination with
nitrite. Studies with patient groups point to
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a role for NOCs in human cancer (15). On
the other hand, several studies reported no or
even an inverse relationship between nitrate
orNOCs andhuman cancer(16-8J).
N-nitrosoproline excretion in urine is fre-
quently used as an indicator of endogenous
nitrosation (NPRO test) (19-22). However,
limited information is available on excretion
of individual (carcinogenic) nitrosamines. In
a recent study, we observed an increase in
peripheral lymphocyte hprt (hypoxanthine-
guanine phosphoribosyltransferase) variant
frequency in users ofwell water containing
high levels of nitrate, in combination with
relatively high urinary excretion levels ofthe
carcinogenic N-nitrosodimethylamine
(NDMA), N-nitrosodiethylamine (NDEA),
N-nitrosopiperidine (NPIP), and N-
nitrosopyrrolidine (NPYR) (23).
The aim ofthe present studywas to inves-
tigate nitrosamine formation after nitrate
exposure at the ADI level. This paper
describes the excretion ofvolatile nitrosamines
in the urine of human volunteers after a
nitrate load in water in combination with a
fish meal, since fish contains high amounts of
amines, which are nitrosatable precursors
(24,25). This study can contribute to the dis-
cussion ofthe validity ofthe current ADI of
nitrate and nitrite for preventing human
health risks.
Materials and Methods
Studypopulation andprotocol Twenty-five
healthy women volunteered to participate
and signed an informed consent. They
agreed to donate saliva samples, collect 24-
hr urine, and to answer a questionnaire on
food consumption and lifestyle habits. The
participants were nonsmokers and used no
medicine or vitamin preparations. The
mean weight of the volunteers [± standard
deviation (SD)] was 60 ± 6 kg (range48-75
kg) and the mean age was 23 ± 7 years
(range 18-46 years).
The study period consisted of 3 weeks:
week 1 was a control week (control week 1),
week 2 the experimental week, and week 3
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was a control week (control week2). During
the control weeks the subjects refrained from
consuming high nitrate-containing food
items; on day 7, a 2-ml saliva sample was
taken (2 hrafter dinner) and 24-hr urine was
collected. During the experimental week, the
participants received a dinner low in nitrate
and containing fish (cod, salmon, shrimp,
pollack) at the University ofMaastricht, in
combination with a KNO3 solution in water
(277 mg KNO3, corresponding to 170 mg
nitrate anion, in 100 ml ofdistilledwater). A
nitrate load in water was used instead of
nitrate-containing vegetables because this
was the most suitable method ofgiving the
volunteers the exact same dose every day.
The total nitrate dose was at the ADI level
forapersonwith abodyweightof60kg (the
mean body weight of the participants).
Assuming a conservative nitrate intake of50
mg/day, even with a diet low in nitrate, the
volunteers consumed 170 mg of nitrate in
water, resulting in a nitrate dose of220 mg
per day. On days 3 and 7, 2-ml saliva sam-
ples were taken at 1, 2, 5, and 23 hr after
nitrate intake. Twenty-four-hour urine was
collected every day, and the volume of the
urine was recorded. Urines ofdays 1, 2, and
Table 1.Thefive N-nitrosamines analysed in urine
N-Nitrosamine
N-Nitrosodimethylamine
N-Nitrosomethylethylamine
N-Nitrosodiethylamine
N-Nitrosopiperidine
N-Nitrosomorpholine
Retention
M+ ion time
(Mlz) (min)
74.05 3.6
88.06 4.7
102.08 5.85
114.08 8.93
116.06 8.50
3 were pooled, and a 100-mi sample was
taken; also urines ofdays 4-7 were pooled
andsampled.
Collection and storage ofsaliva and
urine samples. Two-milliliter saliva samples
were produced after stimulating the salivary
flow by chewing on parafilm and were col-
lected in plastic vials in which 0.2 ml 1 M
NaOH had been evaporated to dryness for
stabilization ofnitrate and nitrite. The 24-hr
urinesampleswere collected in 2-1 containers
with 10 g NaOH pellets. Saliva and urine
sampleswerestored at-20°C until analysis.
Analysis ofnitrate infish meals. The
meals were homogenized, and 10 g was used
for nitrate analysis. Sample preparation and
analysis were performed as described in the
instructions of the Boehringer Mannheim
Nitrate Kit no. 905658 (26).
Analysis ofnitrateandnitrite in saliva.
Saliva samples were deproteinized by
adding 50 pl 1 M ZnSO4 to 0.5 ml ofsali-
va. The mixture was vortexed, placed on
ice for 15 min, and centrifuged for 10 min
at 12,000g. The supernatant was heated at
Table 2. Nitrate excretion in urine (mg/24 hr) dur-
ingthe study protocol
Nitrate
excretion in
urine(mg/24hr),
Time mean ± SD
Controlweek 1 76 ±42
Testweek, days 1-3 194 ±45*
Testweek,days4-7 165 ±40*
Controlweek2 77 ± 41
Nitrate
excretion
as percentof
total dose
SD, standard deviation.
*Significant increase compared with control week 1 and control
week 2(Wilcoxon, p = 0.0001o.
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100°C for 10 min for further deproteiniza-
tion. After centrifugation for 10 min at
12,000g, the nitrate and nitrite concentra-
tions in the supernatant were determined
by HPLC using anion-exchange chro-
matography as previously described (27).
Analysis ofnitrate and nitrite in urine.
One milliliter ofurinewas centrifuged for 10
minat 12,000g, and 50 jl ofthe supernatant
was analyzed for nitrate content with the
spectrophotometric method from Boehr-
inger (Boehringer Mannheim Kit no.
905658) using nitrate reductase (26). We
calculated the amount ofnitrate excreted in
urine by multiplying the urinary nitrate con-
centration with the volume of the 24-hr
urine. Urine samples were screened for
nitrite content with nitrite test strips
(Merckoquant nitrit-test; Merck, Germany).
Analysis ofvolatile nitrosamines in urine.
Volatile nitrosamines, aslisted inTable 1, were
determined by gas chromatography mass spec-
trometry (GC-MS) as previously described
(23) with some modifications. A 20-ml urine
aliquot was extracted with 1 ml dichloro-
methane; 0.5 pI ofthe dichloromethane solu-
tion was splitlessly injected into the GC-MS
system, consisting ofan HP5890 Series II gas
chromatograph (Hewlett-Packard, Avondale,
Pennsylvania) and a Jeol SX1O2A mass spec-
trometer (eol Ltd., Tokyo). The column used
was a WCOT fused silica column (Chrom-
pack, NewJersey), length 50 m, inside diame-
ter 0.25 plm, stationary phase CP-Sil-8 CB-
MS, and film thickness 0.25 pm. Helium was
used as the carrier gas (1 ml/min), and the
injector temperature was 250°C. The column
temperaturewas 50°C for 0.8 min, then rising
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Figure 1. (A) Mean (± standard deviation) salivary nitrate concentrations (mg/I); (B): mean salivary nitrite concentrations(mg/lI) 2 hr aftera meal low in nitrate dur-
ing the control weeks (CW) and 1, 2, 5, and 23 hr after a meal in combination with nitrate intake at2 differentdays during thetestweek(TW).
*Significantly increased compared with CW 1 and CW 2, Wilcoxon, p<0.0004; **significantly decreased compared with 1, 2 and 5 hours after nitrate intake,Wilcoxon, p<0.0004; *significantly increased comparedwith
CW 1 and CW2,Wilcoxon, p<0.0016;"significantly decreased compared with 1, 2 and 5 hr after nitrate intake,Wilcoxon, p<0.0011.
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to 100°C at 9°C/min. After 0.5 min at 100°C,
the temperature rose to 290°C at 35°C/min
and was maintained at 290°C for 5 min. The
mass spectrometer generated ions by electron
ionization at 70 eV. The molecular ions (M+.)
were detected using high-resolution (3000),
single-ion monitoring (HR-SIM). Both reten-
tion time and elemental composition of the
ions were used as proofofthe identity ofthe
measured components. Quantification was
performed by a calibration curve for each of
the nitrosamines, using a nitrosamine mixture
for EPA method 8270 (Aldrich, Zwijndrecht,
the Netherlands). The calibration curves (in
urine) were analyzed analogously to the sam-
ples, adjusting for a possible loss of
nitrosamines during workup. The detection
limit for each nitrosamine was 1 pg/jl of
dichloromethane solution, corresponding to
50pg4llofurine.
In our previous study, we mainly detect-
ed N-nitrosopyrrolidine in urine samples
from subjects exposed to drinking water
with medium or high nitrate levels (23).
However, in a recent study with volunteers
consuming meals with fish and vegetables
rich in nitrate and using mouthwashes, we
predominantly detected NDMA and no
NPYR (28). Therefore, in this study with
comparable nitrosating precursors, the GC-
MS run detecting five volatile nitrosamines
after one injection including NDMA and
excludingNPYRwasperformed.
Statisticalmethods. Results are expressed
as means ± SD. Statistical comparisons ofthe
data with respect to nitrate and nitrite con-
centrations in saliva, nitrate reduction, and
nitrate and nitrosamine excretion in urine
were performed by the nonparametric
Wilcoxon signed-ranks test. Ap-value <0.05
was considered significant, except for
NDMAexcretion in urine, where thep-value
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was compared with an adjusted a of 0.01
because five comparisons were made within
one set ofdata (291. We used linear regres-
sion analysis to examine the relationship
between nitrate and nitrosamine excretion in
urine and between the log transformed
nitrate and nitrite concentration in saliva,
and nitrate and nitrosamine excretion in
urine and between nitrate reduction and
nitrosamine excretion in urine. Ap-value
<0.05 was consideredsignificant.
Results
The mean nitrate intake via the fish meals
consumed during the test weekwas 17 ± 15
mg. The nitrate content of the meals con-
sumed during days 1-3 was slightly higher
than the nitrate content of the meals con-
sumed during days 4-7 (mean nitrate con-
tent 21 and 13 mg, respectively).
Nitrate and nitrite concentrations in
saliva increased significantly after intake of
nitrate at the ADI level (Fig. 1). Peak levels
of both nitrate and nitrite were observed 1
hr after nitrate ingestion. Nitrate concentra-
tions reached a maximumvalue of202 ± 80
mg/l (mean ± SD) at day 3 and 192 ± 107
mg/1 at day 7. Maximum nitrite levels were
32 ± 18 mg/l at day 3 and 32 ± 19 mg/l at
day 7. Nitrate and nitrite levels 2 hr after
nitrate intake were significantly increased
compared with levels 2 hr after a meal low
in nitrate during the control weeks
(Wilcoxon, p<0.0016). Twenty-three hours
after nitrate intake, salivary nitrate and
nitrite concentrations had decreased to
baseline levels.
A significant difference was observed
between nitrate reduction levels (at 2 hr
after the meal) during the control weeks
and during the test week (Wilcoxon, p =
0.001 1). Nitrate reduction during the
control weeks was 25 ± 15% and during the
testweekwas 18 ± 11%.
Table 2 presents data on nitrate excre-
tion in urine. Mean 24-hr nitrate excretion
increased significantly during the test week
compared with the control weeks (p =
0.0001). Nitrate excretion during the test
week, during days 1-3 and days 4-7,
expressed as percentage of the total nitrate
dose (220 mg/day), was 88 and 75%,
respectively. Nitrite was not detected in the
urine samples.
Two N-nitrosamines were detected in
urine samples: NDMA and NPIP. The
results of NDMA excretion in urine are
shown in Figure 2. Mean NDMA excretions
during control week 1, test week days 1-3,
test week days 4-7, and control week 2 were
287 ± 223, 871 ± 430, 640 ± 277, and 383 ±
168 ng/24 hr, respectively. One observation
(during the test week, days 1-3) was identi-
fied as an outlier (more than five times the
SD) and was excluded from all analyses.
Comparisons were made between NDMA
excretions in control week 1 and test week
days 1-3, control week 1 and test week days
4-7, control week 1 and control week 2, test
week days 1-3 and control week 2, and test
week days 4-7 and control week 2. We com-
paredp-valueswith an adjusted aof0.010. A
significant increase in NDMA excretion was
observed during test week days 1-3 and test
weekdays4-7comparedwith controlweek 1
and control week 2 (p<0.0002). There was
no significant difference in NDMA excretion
between the two controlweeks (p = 0.03).
Mean urinary NPIP excretion signifi-
cantly increased during the study relative to
control week 1. During control week 1,
NPIP excretion was 69 ± 36 ng/24 hr, fol-
lowed by an excretion of 86 ± 49 ng/24 hr
during test week days 1-3 (compared with
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Figure 2. N-Nitrosodimethylamine (NDMA) excretion in urine (ng/24 hr) of 24
subjects during control weeks (CW 1 and CW 2) and test week days 1-3 and
4-7 (TWa and TWb).
'Significantly increased compared with CW 1 and CW2;Wilcoxon, p<0.0002.
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Figure 3. Correlation between nitrate excretion in urine and N-nitrosodimethy-
lamine (NDMA) excretion in urine (r= 0.68; p =0.0001).
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control week 1; Wilcoxon, p = 0.008), 94 ±
57 ng/24 hr during test week days 4-7
(Wilcoxon, p = 0.006), and 104 ± 55 ng/24
hr in control week 2 (Wilcoxon, p = 0.002).
NPIP levels in urine were approximately
4-10 times lower than NDMAlevels.
Linear regression analyses ofthe data of
all urine samples of test and control weeks
showed a significant correlation between
urinary nitrate excretion and urinary
NDMA excretion (r= 0.68 andp = 0.0001;
see Fig. 3). No relationship was observed
between nitrate excretion in urine and NPIP
excretion in urine; however, a relationship
was observed between cumulative nitrate
excretion in urine and cumulative NPIP
excretion in urine (r= 0.8 andp = 0.0001).
Furthermore, a correlation was found
between the log ofthe nitrate concentration
in saliva and nitrate excretion in urine (r =
0.70 and p = 0.0001). Finally, correlations
were found between log salivary nitrate con-
centration and NDMA excretion in urine (r
= 0.48; p = 0.0001) and between log nitrite
concentration in saliva and NDMA excre-
tion in urine (r= 0.40;p = 0.0001). No cor-
relation was observed between nitrate reduc-
tion levels andNDMAexcretion in urine.
Discussion
WHO has set guidelines for nitrate and
nitrite intake to prevent the occurrence of
methemoglobinemia. Nitrate exposure, how-
ever, implies other adverse health effects,
including the endogenous formation ofcar-
cinogenic N-nitroso compounds. The pre-
sent study was performed because no infor-
mation is available about N-nitrosamine for-
mation after nitrate intake at the ADI level.
The volunteers in this study received a
nitrate dose of 170 mg in drinking water in
combination with a fish meal low in nitrate
during 1 week. Mean nitrate content ofthe
fish meals was 17 mg/day, and the estimated
nitrate content ofbreakfast, lunch, fruit, and
drinking water consumed during the rest of
the day was approximately 23 mg/day (8),
resulting in a total nitrate dose of210 mg
(estimated range: 185-235 mg). This (con-
servative) nitrate intake will be referred to as
theADI level. Nitrate intake attheADI level
resulted in significantly increased nitrate and
nitrite concentrations in saliva. The mean
rise in salivary nitrate and nitrite concentra-
tion was 73 mg/l and 10 mg/l, respectively,
per 100 mg ofingested nitrate, which is in
agreementwith literaturevalues (4,5,27,30).
Approximately 18% of the salivary
nitratewas reduced to nitrite (meanvalue at
2 hr after nitrate intake) during the test
week, and 25% of the salivary nitrate was
reduced during the control weeks. Other
studies have shown comparable results for
nitrate reduction after a nitrate load (4,27).
On the other hand, no results are reported
on nitrate reduction after a meal low in
nitrate. Nitrate may be reduced more effec-
tively when the amount of nitrate in saliva
is low (31), leading to the relatively high
level ofreduction ofnitrate observed during
the controlweeks.
As expected, nitrate intake at the ADI
level resulted in a significant increase in
mean 24-hr nitrate excretion in urine com-
pared with the control weeks. In the test
week, 88% and 75% of the nitrate dose
was excreted in the urine. Previous reports
have shown that upon nitrate ingestion,
65-70% of the nitrate dose is excreted in
the urine within 24 hr, while about 5% is
converted to nitrite, and the rest is secreted
in sweat (± 10%), in colonic or vaginal
secretions, and in tears (32,33).
Additionally, the urine samples were
screened for nitrite content. Nitrite is not
present in the urine ofhealthy individuals,
but urinary tract infections (frequently pre-
sent in young women) can lead to nitrite
generation in the urinary tract. This implies
the riskofnitrosamine formation in the uri-
nary tract and confounding of the results.
Nitrite was not detected in the urine sam-
ples ofthe femalevolunteers in this study.
Analyses of the urine samples for five
volatile N-nitrosamines showed that two
volatile nitrosamines were present in the
urine: NDMA and NPIP. Two other studies
have been performed with human volunteers
consuming test meals containing nitrate and
fish, inwhich urinesampleswereanalyzedfor
nitrosamine content (28,34). Lakritz et al.
(34) concluded that nitrosamine levels in
urine, blood, andgastricjuicewere notsignif-
icantly affected by ingestion of nitrosamine
precursors. Maanen et al. (28) reported a sig-
nificant increase in NDMA excretion in
urine after consumption of food rich in
nitrate and amines. Yamamoto et al. (35)
measured nitrosamines only in blood, not in
urine, and observed no effect after feeding
eight individuals a Japanese diet rich in
nitrate and amines. Additionally, Tricker et
al. (36) reported that dimethylamine and
piperidine were the most abundant (volatile)
nitrosamine precursors present in gastric
juice. They observed NDMA, NPIP, and
NPYR in the urine of spine-injured para-
plegics (37), and the amounts ofNDMA
excreted arecomparable with our results (650
versus 871 and 640 ng/24 hr), although they
found higher NPIP levels (250 versus 86 and
94 ng/24 hr); we did not analyze the urine
samples for NPYR. However, the
nitrosamines excreted in urine of spine-
injured paraplegics were predominantly
formed in the urinary tract as a result ofbac-
terial infections, while in our study the uri-
nary nitrosamines were probably formed in
thestomach. Thus, urinarynitrosaminelevels
in healthyvolunteers consuming nitrosamine
precursors in combinationwith nitrate intake
at the ADI level are comparable with levels
found in a group at high riskfor nitrosamine
formation. In the control weeks, mean
NDMA excretion in urine was 287 and 383
ng/24 hr, and these results are in agreement
with the 270 ng/24 hr detected in the urine
ofanEgyptiancontrolpopulation (38).
Absolute levels ofvolatile nitrosamines
formed in the stomach are probably much
higher than the amounts excreted in urine.
Spiegelhalder and co-workers (39,40)
showed that between 0.5 and 2.4% of an
ingested NDMA dose was excreted unme-
tabolized in urine if ethanol was adminis-
tered simultaneously. Without concomitant
ethanol intake, less than 0.5% ofthe ingest-
ed NDMA was excreted unmetabolized in
the urine. Assuming that 0.5% of the
NDMA is excreted in urine, the volunteers
in this study may have formed 174 pg of
NDMA per day or 2.9 pg per kg body
weight per day during days 1-3 of the test
week. This exposure can be compared with
the 10 pg NDMA per kg per day that is car-
cinogenic in rats (41). The results clearly
demonstrate that nitrate intake in combina-
tion with fish consumption resulted in an
increase in NDMA excretion in urine of
about 200%. NPIP excretion, on the other
hand, was not directly related to nitrate
intake and the composition ofthe diet con-
sumed during the study. However, a signifi-
cant correlation was found between the
cumulative nitrate excretion in urine and the
cumulative NPIP excretion in urine, suggest-
ing that NPIP formation, in contrast with
NDMA formation, slowly increased after
repeatedhigh nitrate exposure; althoughsub-
sequent metabolism seems to be comparable
with NDMAmetabolism (42-44).
Vegetables contain vitamin C and other
antioxidants that might prevent nitrosamine
formation (45-47). In the present study,
nitrosamine formation did increase during
nitrate intake in combination with a fish
meal, even though the volunteers consumed
vegetables. These vegetables (cauliflower,
peas, carrots, green beans) were low in
nitrate, and their mean vitamin C content
was approximately 17 mg ofvitamin C per
100 g vegetables (48). Thus, the amount of
vitamin C and other antioxidants in these
vegetables appeared insufficient to prevent
nitrosamineformation.
Results of linear regression analyses
showed a good correlation between nitrate
excretion in urine and NDMA excretion in
urine. Additionally, correlations were found
between the log of the salivary nitrate con-
centration and nitrate excretion in urine,
between log salivary nitrate concentration
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and NDMA excretion in urine, and
between log nitrite concentration in saliva
and NDMA excretion in urine. The correla-
tions between urinary nitrate and salivary
nitrate and nitrite versus urinary NDMA
support a relationship between nitrate intake
and endogenous NDMA formation.
In conclusion, nitrate intake at the ADI
level in combination with a fish meal con-
taining nitrosatable precursors increased
NDMA excretion in urine and therefore
implies the risk of increased formation of
carcinogenic N-nitrosamines. The results of
this study suggest that the risk offormation
of carcinogenic N-nitrosamines should be
taken into account in the currently used
ADI value for nitrate and in the drinking
water guideline for nitrate.
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